Close Menu

NEW YORK (GenomeWeb) – Japanese genetic research and testing firm Genesis Healthcare announced today that it has completed the sale of ¥1.5 billion ($13.8 million) of newly issued shares to Rakuten.

In connection with the transaction, Rakuten Chairman and CEO Hiroshi Mikitani will join Genesis' board as an external director.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.